The immune reconstitution inflammatory syndrome: etiology, pathogenesis, clinical manifestations
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2019, Vol 0, Issue 1
Abstract
Increasing of HIV-infection incidence in many countries of the world and in Ukraine in particular, late identification of patients and an increase in the power of antiretroviral therapy requires the doctors to treat the immune reconstitution inflammatory syndrome. The polymorphism of its manifestations and the delay in the onset of symptoms from the start of antiretroviral therapy make it difficult to diagnose this pathological condition timely and prescribe adequate treatment. In this work, a review of the literature on the problems of the immune reconstitution inflammatory syndrome has been conducted and the characteristics of it etiology, pathogenesis and clinical manifestations have been systematized. The main causes and mechanisms of the appearance of the unmasking and paradoxical forms of the immune reconstitution inflammatory syndrome were described. The global epidemiological data on the prevalence of immune reconstitution inflammatory syndrome and mortality from it various forms were analyzed. The main variants of the immune reconstitution inflammatory syndrome, namely tuberculosis-associated immune reconstitution inflammatory syndrome, сryptococcus-associated immune reconstitution inflammatory syndrome, and immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma, are considered. The most specific lesion sites, such as the central nervous system, skin, and mucous membranes were described. The criteria for the diagnosis of the most common forms of the immune reconstitution inflammatory syndrome were summarized. The main recommendations for the treatment and prevention of the immune reconstitution inflammatory syndrome, based on the world clinical researches, as well as expert opinions on the use of certain treatment methods for various conditions associated with the immune reconstitution inflammatory syndrome were presented. The main problems and future prospects of research in this direction were identified.
Authors and Affiliations
O. S. Shevchenko, V. I. Petrenko, L. D. Todoriko, O. O. Pohorielova
Keywords
Related Articles
- EP ID EP607138
- DOI 10.30978/TB2019-1-63
- Views 110
- Downloads 0
Algorithm of use short 12 month regimens for the linezolid based for patients with multidrug-resistant tuberculosis: first encouraging results
Objective — to formulate clear algorithms for use of short 12 month regimens based on linezolid, with differentiation indications depending on the resistance profile of the MBT (MDR, preXDR, risk MDR), develop clear incl...
New approaches in latent TB infection detection and management
The review of WHO approaches related to latent TB infection (LTI) is presented. Prospective of different methods of LTI testing in Ukraine given significant TB burden and insufficient domestic resources is discussed. Giv...
WHO consolidated guidelines on drug-resistant tuberculosis treatment. Part 1
_
Guidance on requirements for QTc measurement in ECG monitoring when introducing new drugs and shorter regimens for the treatment of Drug-resistant Tuberculosis
-
Study of cell death kinds and stages of leukocytes apoptosis in pulmonary tuberculosis patient during antimycobacterial therapy
Objective — to evaluate the condition of cytoplasmic membranes of leukocytes and to study their viability, to determine the varieties and stages of cell death of leukocytes in patients with pulmonary tuberculosis (TB) wi...